Literature DB >> 4125154

The macrophage electrophoretic migration test in cancer.

A H Goldstone, L Kerr, W J Irvine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4125154      PMCID： PMC1553818     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  6 in total

1.  M.E.M. test for malignant disease.

Authors:  E J Field; E A Caspary
Journal:  Lancet       Date:  1972-10-14       Impact factor: 79.321

2.  Glucagon.

Authors: 
Journal:  Lancet       Date:  1972-09-23       Impact factor: 79.321

3.  Immunodiagnosis of cancer.

Authors:  J A Pritchard; J L Moore; W H Sutherland; C A Joslin
Journal:  Br Med J       Date:  1972-09-30

4.  Purification of lymphocytes and platelets by gradient centrifugation.

Authors:  R J Perper; T W Zee; M M Mickelson
Journal:  J Lab Clin Med       Date:  1968-11

5.  Lymphocyte sensitisation: an in-vitro test for cancer?

Authors:  E J Field; E A Caspary
Journal:  Lancet       Date:  1970-12-26       Impact factor: 79.321

6.  Specific lymphocyte sensitization in cancer: is there a common antigen in human malignant neoplasia?

Authors:  E A Caspary; E J Field
Journal:  Br Med J       Date:  1971-06-12
  6 in total
  21 in total

1.  Macrophage electrophoretic mobility (MEM) test in malignant gynaecological diseases.

Authors:  H L Jenssen; H Köhler; J Günther; B Klausch; W Straube; R Hofmann; H H Büttner
Journal:  Arch Gynakol       Date:  1976-03-05

2.  Role of immunity in diagnosis of human cancer. Discussion.

Authors: 
Journal:  Br J Cancer Suppl       Date:  1973-08

3.  Scrapie: a review of its relation to human disease and ageing.

Authors:  E J Field
Journal:  J Med Genet       Date:  1976-12       Impact factor: 6.318

4.  [The electrophoretic-mobility-(EM) test: a method for discrimination of malignant and non-malignant tumors (author's transl)].

Authors:  C Tautz; W Schneider; E Laier; G Brügmann
Journal:  Klin Wochenschr       Date:  1978-02-15

5.  The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.

Authors:  A W Preece; P A Light
Journal:  Clin Exp Immunol       Date:  1974-12       Impact factor: 4.330

6.  Lymphoproliferative response as an index of cellular immunity in malignant melanoma of the uvea and its correlation with the histological features of the tumour.

Authors:  M S Sunba; A H Rahi; G Morgan; E J Holborow
Journal:  Br J Ophthalmol       Date:  1980-08       Impact factor: 4.638

7.  Studies with the macrophage migration inhibition (MMI) test in patients with malignant disease.

Authors:  P A Light; A W Preece; H A Waldron
Journal:  Clin Exp Immunol       Date:  1975-11       Impact factor: 4.330

Review 8.  Human tumour-associated and tumour-specific antigens: some concepts in relation to clinical oncology.

Authors:  A M Neville; A M Mackay; J Westwood; C Turberville; D J Laurence
Journal:  J Clin Pathol Suppl (Assoc Clin Pathol)       Date:  1975

9.  Immunological cross-reactivity between basic proteins of myelin and cancer. I. Lymphocyte transformation studies in immunized guinea-pigs.

Authors:  A S Coates; P R Carnegie
Journal:  Clin Exp Immunol       Date:  1975-10       Impact factor: 4.330

10.  An assessment of the macrophage electrophoretic mobility test (MEM) in cancer diagnosis.

Authors:  E H Crozier; M E Hollinger; B E Woodend; J H Robertson
Journal:  J Clin Pathol       Date:  1976-07       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.